Related Experiment Video
Updated: Jul 16, 2026

Prion Safety Laboratory Swipe Test
Published on: February 14, 2025
Blood transfusion and spread of variant Creutzfeldt-Jakob disease
Klaus Dietz1, Günter Raddatz, Jonathan Wallis
1University of Tübingen, Tübingen, Germany. klaus.dietz@uni-tuebingen.de
Insights
Excluding blood donors who received transfusions prevents less than 1% of variant Creutzfeldt-Jakob disease (vCJD) cases. This measure is ineffective for preventing vCJD transmission via blood components alone.
Area of Science:
- Epidemiology
- Infectious Disease Transmission
- Public Health Policy
Background:
- Variant Creutzfeldt-Jakob disease (vCJD) poses a potential risk for transmission through blood transfusions.
- Several countries have implemented donor deferral policies, excluding individuals with a history of blood transfusion to mitigate this risk.
Purpose of the Study:
- To evaluate the effectiveness of excluding blood donors with a history of transfusion in preventing vCJD transmission.
- To model the potential impact of this policy on vCJD epidemiology.
Main Methods:
- Development of a dynamic, age-structured mathematical model.
- Incorporation of epidemiologic data including blood donor activities, vCJD case-control data, recipient age distribution, and recipient mortality rates.
Main Results:
- The model predicts that vCJD, introduced via the alimentary route, cannot become endemic solely through blood transfusion.
- Excluding individuals who have received blood transfusions is projected to prevent fewer than 1% of vCJD cases.
Conclusions:
- The current policy of excluding blood donors with a transfusion history is largely ineffective in preventing vCJD spread.
- Alternative or supplementary strategies are likely necessary to control vCJD transmission through the blood supply.
Abstract:
Variant Creutzfeldt-Jakob disease (vCJD) may be transmissible by blood. To prevent secondary transmission through blood components, several countries have started to exclude as donors persons who have received a blood transfusion. We investigated the effectiveness of this measure by using a dynamic age-structured model. It is the first such model based on epidemiologic data: 1) blood donor activities, 2) a case-control study on CJD, 3) age distribution of recipients, and 4) death of recipients of blood transfusions. The model predicts that an infection like vCJD, which has been introduced into the population by the alimentary route, could not become endemic by transfusion alone and that only <1% of cases would be avoided by excluding from blood donation those persons who have received a transfusion.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Viral Recombination
Transmission of Pathogens
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...

